Fosgonimeton

N/A

Report date: 2024/05/06 17:48:36
NME

Base Information

Drug NameFosgonimeton
Drug Alias NameCompound A19NDX-1017ATH-1017ATH 1017
ClassificationSmall molecules > Synthetic peptideSmall molecules > Heterocyclic drugs
Mechanisms of ActionHepatocyte growth factor stimulantsHepatocyte growth factor receptor agonists
TargetsHepatocyte growth factorHepatocyte growth factor receptor
Therapy Area/IndicationsAlzheimer DiseaseDementiaParkinson Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesM3 Biotechnology
China Registration ClassN/A

Develop Information

Active CompaniesAthira Pharma Inc
Inactive CompaniesN/A
Active IndicationsAlzheimer DiseaseDementia
Inactive IndicationsParkinson DiseaseLewy Body Disease

Other Information

ATC CodeN/A
Related LinksN/A